Feasibility of conducting cardiovascular outcome research in Australian general practice: Results from the ANBP2 pilot study

1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up, Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme, Blood pressure was measured on three occasions and eligible subjects were included if the average BP was greater than or equal to 160 mmHg systolic or greater than or equal to 90 mmHg diastolic if systolic BP was greater than or equal to 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening, Twenty-two per cent of eligible subjects attended screening, Of 1938 subjects screened, 180 (9%) had BP greater than or equal to 160/90 mmHg, Forty-seven per cent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy, One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks, Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial.